NEW YORK – In a move that signals a return to good standing, Japan-based holistic healthcare company MEDIROM Healthcare Technologies Inc. (MRM), has announced it has regained compliance with Nasdaq’s minimum bid price requirement. The announcement, made on June 5, 2025, follows a period of uncertainty for the company’s American Depositary Shares (ADSs).
Back on February 27, 2025, MEDIROM received a notice from Nasdaq due to non-compliance with the $1.00 minimum closing bid price. The exchange provided the company with a mandated 180-day period, extending to August 26, 2025, to rectify the situation. The road to recovery required the ADSs to maintain a closing bid price of at least $1.00 for ten consecutive business days.
MEDIROM’s efforts have paid off. Nasdaq confirmed on June 4, 2025, that from May 20, 2025, to June 3, 2025, the ADSs closed at or above the $1.00 mark, thereby satisfying the requirement. Nasdaq has subsequently informed MEDIROM that it has regained compliance with Listing Rule 5550(a)(2) and that the matter is now closed. This positive development offers a breath of fresh air for investors and signals the company’s commitment to adhering to exchange regulations.
About MEDIROM Healthcare Technologies Inc.
MEDIROM stands as a prominent player in Japan’s wellness landscape, boasting a network of over 300 wellness salons under its flagship brand, Re.Ra.Ku®. The company provides an array of healthcare services. Beyond its salon operations, MEDIROM has diversified its offerings. In 2015, the company ventured into the health-tech sphere, launching its proprietary on-demand training app, “Lav®.” In 2020, it expanded further into the device sector with the development of the “MOTHER Bracelet®” smart tracker. The recent introduction of REMONY in 2023, a remote monitoring system, highlights MEDIROM’s expansion into corporate clients. This system has secured orders across a diverse range of industries, including nursing care, transportation, and manufacturing. MEDIROM’s strategy centres on leveraging its portfolio of health-related products and services to consolidate and utilize customer healthcare data, with the aim of positioning itself as a leader in healthcare big data within Japan. For further information, visit https://medirom.co.jp/en.
Forward-Looking Statements
This press release contains forward-looking statements that offer a glimpse into MEDIROM’s future, however, they are not guarantees. These statements are made under the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. They encompass potential future performance, financial condition, business strategies, and market opportunities. These statements may use words like “may,” “will,” “should,” “expect,” “anticipate,” or similar terms that indicate uncertainty about future events. Investors should be aware that actual results could significantly differ from those that are implied by forward-looking statements due to business, economic, and regulatory risks, many of which are beyond MEDIROM’s control. While MEDIROM’s management believes its assumptions and expectations are reasonable, the company isn’t obligated to update forward-looking statements, even as new information emerges.
Original article, Author: Jam. If you wish to reprint this article, please indicate the source:https://aicnbc.com/1829.html
